Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for E9Q4Z2

Entry ID Method Resolution Chain Position Source
AF-E9Q4Z2-F1 Predicted AlphaFoldDB

114 variants for E9Q4Z2

Variant ID(s) Position Change Description Diseaes Association Provenance
rs3388777524 39 A>T No EVA
rs51877709 40 N>S No EVA
rs240131872 55 G>E No EVA
rs3388777578 60 E>V No EVA
rs225090511 64 H>Q No EVA
rs45917980 64 H>R No EVA
rs3388753754 78 Q>* No EVA
rs232958066 78 Q>H No EVA
rs47813780 88 R>K No EVA
rs3388767913 97 N>T No EVA
rs3388781546 98 D>H No EVA
rs3388782653 101 P>T No EVA
rs215608464 109 W>C No EVA
rs226038449 110 T>P No EVA
rs212554964 112 A>G No EVA
rs3388770646 120 A>T No EVA
rs217854757 130 P>L No EVA
rs3388788746 136 S>F No EVA
rs3388782143 140 E>G No EVA
rs3388781568 155 F>I No EVA
rs3388775226 180 K>R No EVA
rs3388770669 206 T>I No EVA
rs3388785795 225 K>N No EVA
rs3396016677 237 P>Q No EVA
rs3395958201 238 A>T No EVA
rs3411342105 272 W>* No EVA
rs3388753685 280 E>K No EVA
rs232572141 284 R>W No EVA
rs3388782418 338 W>* No EVA
rs3395679169 343 H>P No EVA
rs3388782675 373 G>R No EVA
rs3396086846 382 A>P No EVA
rs3388781630 400 E>* No EVA
rs3388782187 476 G>D No EVA
rs3388781598 479 I>T No EVA
rs3388782155 493 V>I No EVA
rs3388767838 494 Q>H No EVA
rs3388782123 503 A>V No EVA
rs3388779791 533 V>M No EVA
rs3388762986 570 E>* No EVA
rs3388767878 573 P>L No EVA
rs3388788757 580 P>T No EVA
rs3388777559 593 A>T No EVA
rs3388782668 602 P>H No EVA
rs3388782638 666 S>G No EVA
rs3388767892 673 Y>N No EVA
rs3388782141 680 G>W No EVA
rs3388762934 694 F>S No EVA
rs3388782655 770 L>F No EVA
rs3388781608 807 L>M No EVA
rs3388767884 821 Q>H No EVA
rs3388782430 835 I>M No EVA
rs3388770653 859 Y>* No EVA
rs3388767876 897 Q>H No EVA
rs3388781586 900 V>M No EVA
rs3388778685 905 H>R No EVA
rs3388770692 941 I>L No EVA
rs3388775188 948 V>M No EVA
rs3395679771 1004 E>G No EVA
rs3395673593 1013 D>V No EVA
rs3388779779 1018 L>P No EVA
rs3388785821 1049 K>Q No EVA
rs3388773485 1062 I>V No EVA
rs3388788696 1079 D>G No EVA
rs3388782483 1102 V>A No EVA
rs3388779797 1142 C>S No EVA
rs3388779786 1156 Q>R No EVA
rs3388782600 1202 L>P No EVA
rs3388781584 1303 E>V No EVA
rs3388781629 1335 D>H No EVA
rs3388753710 1364 R>I No EVA
rs3388767867 1379 F>Y No EVA
rs47121625 1387 L>P No EVA
rs3388785824 1431 V>I No EVA
rs3388782198 1533 R>Q No EVA
rs3388773504 1596 K>M No EVA
rs3388785863 1616 R>* No EVA
rs3388775207 1619 Q>H No EVA
rs3388762933 1631 S>* No EVA
rs3388767900 1639 L>I No EVA
rs3388775202 1716 Q>* No EVA
rs3388785831 1729 P>L No EVA
rs3388753691 1751 R>L No EVA
rs3388788740 1759 G>D No EVA
rs3388783382 1774 E>D No EVA
rs220649250 1779 V>I No EVA
rs3388781623 1786 T>N No EVA
rs3388770703 1804 S>Y No EVA
rs3388785798 1805 E>V No EVA
rs3388788691 1851 Y>N No EVA
rs3388782623 1899 R>G No EVA
rs1134351994 1919 S>G No EVA
rs33236572 1925 A>T No EVA
rs3388767874 1933 V>M No EVA
rs3388773473 1954 A>T No EVA
rs3388782480 1954 A>V No EVA
rs3388775215 1971 G>S No EVA
rs3388777493 2005 K>R No EVA
rs3388782414 2007 N>D No EVA
rs3388788699 2011 V>I No EVA
rs3388775222 2101 D>H No EVA
rs50223129 2120 F>C No EVA
rs3388775255 2158 Y>C No EVA
rs3388777489 2183 I>L No EVA
rs3388773464 2249 V>M No EVA
rs3388775174 2311 T>I No EVA
rs3388775187 2350 R>L No EVA
rs3396087665 2357 E>A No EVA
rs3388773496 2368 N>S No EVA
rs49366190 2388 T>N No EVA
rs3388775236 2391 E>V No EVA
rs3388777551 2392 N>S No EVA
rs3388775245 2396 L>Q No EVA
rs3388781243 2408 L>P No EVA

No associated diseases with E9Q4Z2

10 regional properties for E9Q4Z2

Type Name Position InterPro Accession
domain Biotin/lipoyl attachment 878 - 952 IPR000089
domain Carbamoyl-phosphate synthetase large subunit-like, ATP-binding domain 421 - 604 IPR005479
domain Biotin carboxylase-like, N-terminal domain 250 - 369 IPR005481
domain Biotin carboxylase, C-terminal 640 - 747 IPR005482
domain ATP-grasp fold 408 - 599 IPR011761
domain Acetyl-coenzyme A carboxyltransferase, N-terminal 1685 - 2015 IPR011762
domain Acetyl-coenzyme A carboxyltransferase, C-terminal 2019 - 2335 IPR011763
domain Biotin carboxylation domain 249 - 751 IPR011764
domain Acetyl-CoA carboxylase, central domain 952 - 1678 IPR013537
domain Acetyl-CoA carboxylase 1770 - 2323 IPR034733

Functions

Description
EC Number 6.4.1.2 Forming carbon-carbon bonds
Subcellular Localization
  • Mitochondrion
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

2 GO annotations of cellular component

Name Definition
mitochondrion A semiautonomous, self replicating organelle that occurs in varying numbers, shapes, and sizes in the cytoplasm of virtually all eukaryotic cells. It is notably the site of tissue respiration.
nucleus A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.

5 GO annotations of molecular function

Name Definition
acetyl-CoA carboxylase activity Catalysis of the reaction: ATP + acetyl-CoA + HCO3- = ADP + phosphate + malonyl-CoA.
ATP binding Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
biotin binding Binding to biotin (cis-tetrahydro-2-oxothieno(3,4-d)imidazoline-4-valeric acid), the (+) enantiomer of which is very widely distributed in cells and serves as a carrier in a number of enzymatic beta-carboxylation reactions.
identical protein binding Binding to an identical protein or proteins.
metal ion binding Binding to a metal ion.

16 GO annotations of biological process

Name Definition
acetyl-CoA metabolic process The chemical reactions and pathways involving acetyl-CoA, a derivative of coenzyme A in which the sulfhydryl group is acetylated; it is a metabolite derived from several pathways (e.g. glycolysis, fatty acid oxidation, amino-acid catabolism) and is further metabolized by the tricarboxylic acid cycle. It is a key intermediate in lipid and terpenoid biosynthesis.
energy homeostasis Any process involved in the balance between food intake (energy input) and energy expenditure.
fatty acid biosynthetic process The chemical reactions and pathways resulting in the formation of a fatty acid, any of the aliphatic monocarboxylic acids that can be liberated by hydrolysis from naturally occurring fats and oils. Fatty acids are predominantly straight-chain acids of 4 to 24 carbon atoms, which may be saturated or unsaturated; branched fatty acids and hydroxy fatty acids also occur, and very long chain acids of over 30 carbons are found in waxes.
malonyl-CoA biosynthetic process The chemical reactions and pathways resulting in the formation of malonyl-CoA, the S-malonyl derivative of coenzyme A.
negative regulation of catalytic activity Any process that stops or reduces the activity of an enzyme.
negative regulation of fatty acid beta-oxidation Any process that stops, prevents, or reduces the frequency, rate or extent of fatty acid beta-oxidation.
negative regulation of fatty acid oxidation Any process that stops, prevents, or reduces the frequency, rate or extent of fatty acid oxidation.
negative regulation of gene expression Any process that decreases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product (protein or RNA).
negative regulation of lipid catabolic process Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of lipids.
positive regulation of heart growth Any process that increases the rate or extent of heart growth. Heart growth is the increase in size or mass of the heart.
positive regulation of lipid storage Any process that increases the rate, frequency or extent of lipid storage. Lipid storage is the accumulation and maintenance in cells or tissues of lipids, compounds soluble in organic solvents but insoluble or sparingly soluble in aqueous solvents. Lipid reserves can be accumulated during early developmental stages for mobilization and utilization at later stages of development.
protein homotetramerization The formation of a protein homotetramer, a macromolecular structure consisting of four noncovalently associated identical subunits.
regulation of glucose metabolic process Any process that modulates the rate, frequency or extent of glucose metabolism. Glucose metabolic processes are the chemical reactions and pathways involving glucose, the aldohexose gluco-hexose.
response to nutrient levels Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus reflecting the presence, absence, or concentration of nutrients.
response to organic cyclic compound Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic cyclic compound stimulus.
response to xenobiotic stimulus Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a xenobiotic, a compound foreign to the organim exposed to it. It may be synthesized by another organism (like ampicilin) or it can be a synthetic chemical.

5 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
P11029 ACAC Acetyl-CoA carboxylase Gallus gallus (Chicken) PR
Q13085 ACACA Acetyl-CoA carboxylase 1 Homo sapiens (Human) PR
O00763 ACACB Acetyl-CoA carboxylase 2 Homo sapiens (Human) PR
Q5SWU9 Acaca Acetyl-CoA carboxylase 1 Mus musculus (Mouse) PR
P11497 Acaca Acetyl-CoA carboxylase 1 Rattus norvegicus (Rat) PR
10 20 30 40 50 60
MVLLLFLTCL VFSCLTFSWL KIWGKMTDSK PLTNSKVEAN LLSSEESLSA SELSGEQLQE
70 80 90 100 110 120
HGDHSCLSYR GPRDASQQRN SLPSSCQRPP RNPLSSNDTW PSPELQTNWT AAPGPEVPDA
130 140 150 160 170 180
NGLSFPARPP SQRTVSPSRE DRKQAHIKRQ LMTSFILGSL DDNSSDEDPS AGSFQNSSRK
190 200 210 220 230 240
SSRASLGTLS QEAALNTSDP ESHAPTMRPS MSGLHLVKRG REHKKLDLHR DFTVASPAEF
250 260 270 280 290 300
VTRFGGNRVI EKVLIANNGI AAVKCMRSIR RWAYEMFRNE RAIRFVVMVT PEDLKANAEY
310 320 330 340 350 360
IKMADQYVPV PGGPNNNNYA NVELIIDIAK RIPVQAVWAG WGHASENPKL PELLCKHEIA
370 380 390 400 410 420
FLGPPSEAMW ALGDKIASTI VAQTLQIPTL PWSGSGLTVE WTEDSRHQGK CISVPEDVYE
430 440 450 460 470 480
QGCVKDVDEG LQAAEKIGFP LMIKASEGGG GKGIRKAESA EDFPMLFRQV QSEIPGSPIF
490 500 510 520 530 540
LMKLAQNARH LEVQVLADQY GNAVSLFGRD CSIQRRHQKI IEEAPATIAA PAVFEFMEQC
550 560 570 580 590 600
AVLLAKMVGY VSAGTVEYLY SQDGSFHFLE LNPRLQVEHP CTEMIADVNL PAAQLQIAMG
610 620 630 640 650 660
VPLHRLKDIR LLYGESPWGV TPIPFETPLS PPIARGHVIA ARITSENPDE GFKPSSGTVQ
670 680 690 700 710 720
ELNFRSNKNV WGYFSVAAAG GLHEFADSQF GHCFSWGENR EEAISNMVVA LKELSIRGDF
730 740 750 760 770 780
RTTVEYLVNL LETESFQNND IDTGWLDHLI AQRVQAEKPD IMLGVVCGAL NVADAMFRTC
790 800 810 820 830 840
MTEFLHSLER GQVLPADSLL NIVDVELIYG GIKYALKVAR QSLTMFVLIM NGCHIEIDAH
850 860 870 880 890 900
RLNDGGLLLS YNGSSYTTYM KEEVDSYRIT IGNKTCVFEK ENDPTVLRSP SAGKLMQYTV
910 920 930 940 950 960
EDGDHVEAGS SYAEMEVMKM IMTLNVQESG RVKYIKRPGV ILEAGCVVAR LELDDPSKVH
970 980 990 1000 1010 1020
AAQPFTGELP AQQTLPILGE KLHQVFHGVL ENLTNVMSGY CLPEPFFSMK LKDWVQKLMM
1030 1040 1050 1060 1070 1080
TLRHPSLPLL ELQEIMTSVA GRIPAPVEKA VRRVMAQYAS NITSVLCQFP SQQIATILDC
1090 1100 1110 1120 1130 1140
HAATLQRKAD REVFFMNTQS IVQLVQRYRS GTRGYMKAVV LDLLRKYLNV EHHFQQAHYD
1150 1160 1170 1180 1190 1200
KCVINLREQF KPDMTQVLDC IFSHSQVAKK NQLVTMLIDE LCGPDPTLSD ELTSILCELT
1210 1220 1230 1240 1250 1260
QLSRSEHCKV ALRARQVLIA SHLPSYELRH NQVESIFLSA IDMYGHQFCP ENLKKLILSE
1270 1280 1290 1300 1310 1320
TTIFDVLPTF FYHENKVVCM ASLEVYVRRG YIAYELNSLQ HRELPDGTCV VEFQFMLPSS
1330 1340 1350 1360 1370 1380
HPNRMAVPIS VSNPDLLRHS TELFMDSGFS PLCQRMGAMV AFRRFEEFTR NFDEVISCFA
1390 1400 1410 1420 1430 1440
NVQTDTLLFS KACTSLYSEE DSKSLREEPI HILNVAIQCA DHMEDEALVP VFRAFVQSKK
1450 1460 1470 1480 1490 1500
HILVDYGLRR ITFLVAQERE FPKFFTFRAR DEFAEDRIYR HLEPALAFQL ELSRMRNFDL
1510 1520 1530 1540 1550 1560
TAVPCANHKM HLYLGAAKVK EGLEVTDHRF FIRAIIRHSD LITKEASFEY LQNEGERLLL
1570 1580 1590 1600 1610 1620
EAMDELEVAF NNTSVRTDCN HIFLNFVPTV IMDPLKIEES VRDMVMRYGS RLWKLRVLQA
1630 1640 1650 1660 1670 1680
EVKINIRQTT SDSAIPIRLF ITNESGYYLD ISLYREVTDS RSGNIMFHSF GNKQGSLHGM
1690 1700 1710 1720 1730 1740
LINTPYVTKD LLQAKRFQAQ SLGTTYVYDF PEMFRQALFK LWGSPEKYPK DILTYTELVL
1750 1760 1770 1780 1790 1800
DSQGQLVEMN RLPGCNEVGM VAFKMRFKTP EYPEGRDAVV IGNDITFQIG SFGIGEDFLY
1810 1820 1830 1840 1850 1860
LRASEMARTE GIPQIYLAAN SGARMGLAEE IKQIFQVAWV DPEDPHKGFR YLYLTPQDYT
1870 1880 1890 1900 1910 1920
QISSQNSVHC KHIEDEGESR YVIVDVIGKD ANLGVENLRG SGMIAGEASL AYEKTVTISM
1930 1940 1950 1960 1970 1980
VTCRALGIGA YLVRLGQRVI QVENSHIILT GAGALNKVLG REVYTSNNQL GGVQIMHTNG
1990 2000 2010 2020 2030 2040
VSHVTVPDDF EGVCTILEWL SFIPKDNRSP VPITTPSDPI DREIEFTPTK APYDPRWMLA
2050 2060 2070 2080 2090 2100
GRPHPTLKGT WQSGFFDHGS FKEIMAPWAQ TVVTGRARLG GIPVGVIAVE TRTVEVAVPA
2110 2120 2130 2140 2150 2160
DPANLDSEAK IIQQAGQVWF PDSAYKTAQV IRDFNKERLP LMIFANWRGF SGGMKDMYEQ
2170 2180 2190 2200 2210 2220
MLKFGAYIVD GLRLYEQPIL IYIPPCAELR GGSWVVLDST INPLCIEMYA DKESRGGVLE
2230 2240 2250 2260 2270 2280
PEGTVEIKFR KKDLVKTIRR IDPVCKKLVG QLGKAQLPDK DRKELEGQLK AREELLLPIY
2290 2300 2310 2320 2330 2340
HQVAVQFADL HDTPGHMLEK GIISDVLEWK TARTFFYWRL RRLLLEAQVK QEILRASPEL
2350 2360 2370 2380 2390 2400
NHEHTQSMLR RWFVETEGAV KAYLWDSNQV VVQWLEQHWS AKDGLRSTIR ENINYLKRDS
2410 2420 2430 2440
VLKTIQSLVQ EHPEVIMDCV AYLSQHLTPA ERIQVAQLLS TTESPASS